Gwalior Hospital Halts Azithromycin Batch After Complaint of Worm‑Like Particles

Overview

• Samples from the Azithromycin oral suspension batch were sent to the state drug lab in Bhopal, and a sample is to be tested at the Central Drug Laboratory in Kolkata.
• On-site checks noted one or two black particles in the opened bottle, and a visiting team of pharmaceutical experts reported no issues in several other bottles examined.
• The batch in question was supplied through a government store in Bhopal, and authorities are tracing distribution while halting dispensing at affected centres.
• Local officials identified the manufacturer as Indore-based Zenith Drugs Ltd., and warned of legal action if testing finds the product substandard or harmful.
• No illnesses tied to this batch have been reported, and the complaint comes as pediatric drug safety faces heightened scrutiny following child deaths linked to contaminated Coldrif cough syrup and a WHO alert on substandard syrups.